Devon Energy Corp vs Zimmer Biomet Holdings Inc — how do they compare? Devon Energy Corp trades at $43.12 (market cap $49.52B), while Zimmer Biomet Holdings Inc trades at $92.83 (market cap $17.44B). The key difference: Devon Energy Corp is far larger — about 2.8× Zimmer Biomet Holdings Inc's market cap, and Devon Energy Corp pays the higher dividend (2.42%). Which is the better fit depends on your goals.
| DVN | ZBH | |
|---|---|---|
Market Cap | $49.52B | $17.44B |
Sector | Energy | Health |
52-Week High | $52.07 | $107.71 |
52-Week Low | $31.74 | $79.58 |
Enterprise Value | $56.29B | $24.49B |
Dividend Yield | 2.42% | 1.07% |
Signals from Pluang's Aura AI — not financial advice
Devon Energy (DVN) trades at $43.35, down 0.12% on the day, with a neutral technical signal and bullish moving averages. The stock shows strong fundamentals with a P/E of 11.96, net income margin of 13.71%, and consistent cash flow generation. Recent news highlights activist pressure for asset sales and the integration benefits from the Coterra acquisition, targeting $2 billion in synergies by 2027.
DVN presents a compelling value opportunity with analyst consensus bullish (71% buy ratings) and a price target of $60.18, implying 39% upside. Risks include volatile energy prices, execution of merger synergies, and activist investor demands. Earnings growth and free cash flow remain key catalysts for shareholder returns.
Zimmer Biomet (ZBH) trades at $91.03, down 3.24% on the day, with a bullish technical signal from moving averages and neutral oscillators. The stock shows consistent earnings beats in recent quarters, with Q2 2026 results pending. Revenue growth has climbed from $6.9B in 2022 to $8.2B in 2025, though net income margin dipped to 8.56%. Recent corporate developments include a $140M acquisition and expansion in India, supporting long-term growth initiatives.
The outlook remains cautiously optimistic with a consensus price target of $97.67, implying 7% upside. Key opportunities include operational efficiency and market share gains, while risks involve debt levels rising to 32.57% of assets and competitive pressures in medical technology. Earnings on August 5 will be critical for near-term direction.
Trailing returns across standard periods
Latest headlines on both assets
Devon Energy, based in Oklahoma City, is one of the largest independent exploration and production companies in North America. The firm's asset base is spread throughout onshore North America and includes exposure to the Delaware, STACK, Eagle Ford, Powder River Basin, and Bakken plays. At year-end 2021, Devon's proved reserves totaled 1.6 billion barrels of oil equivalent, and net production that year was 572 thousand boe/d, of which oil and natural gas liquids made up 74% of production, with natural gas accounting for the remainder.
Read more on DVN →Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →